Access cutting-edge multiple myeloma treatment through this clinical trial at a research site in Beverly Hills. Study-provided care at no cost to qualified participants.
Access multiple myeloma specialists in Beverly Hills at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multiple myeloma treatment provided free
The purpose of this Phase 3 study is to evaluate if BRd prolongs progression free survival (PFS) and/or improves minimal residual disease (MRD) negative status compared with DRd in participants with TI-NDMM.
Sponsor: GlaxoSmithKline
Check if you qualify for this multiple myeloma clinical trial in Beverly Hills, CA
If you're searching for multiple myeloma treatment options in Beverly Hills, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Beverly Hills research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple myeloma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.